ICNA President-Elect Elections 2024 are currently underway. All eligible voters (ICNA Full Members) have been emailed their unique voting credentials. All voting is done via the secure platform at https://icnapedia.org/pe2024. The voting site will remain open until 2400hrs GMT on 1 May 2024.
I have successfully completed my administrative responsibilities as active member and chair of the Steering Committee, International Paediatric MS Study Group (IPMSSG), and I am currently contributing as chair of the Nominating Committee of this study group. I have participated in several Paediatric MS Workshops, publishing consensus definitions for Paediatric MS, ADEM, and NMO. As member of the IPMSSG, we contributed to research activities on paediatric MS, we developed treatment guidelines for paediatric patients, and promoted education at international levels. The Summit in 2012 (Washington) and more recently the Boston Paediatric MS Global Update (2014) are highlighted examples.
I have enjoyed being a member of the International Panel for NMO diagnostic criteria task force, as chair of the paediatric subcommittee. And since 2014 I have been elected member of the Executive Board, International Child Neurology Association (ICNA).
My main interest is the investigation of acquired CNS inflammatory and demyelinating disorders in the paediatric population. I have worked and continue working towards advocating for better services and care to children with MS, NMO, ADEM, and immune-mediated encephalopathies throughout the world, and particularly in my region, South America, providing my clinical and research experience in the growing area of neuroimmunology.